News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Sleep Apnea Device Start-Up Pavad Medical Closes $7.5M Series B
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
8/19/2005 Pavad Medical Inc., which is developing an implantable device to treat obstructive sleep apnea, closed a $7.5 million Series B round last week, Canaan Partners General Partner Brent Ahrens told VentureWire.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Cell therapy
Vor Bio Looks for Exit in Challenging Funding Environment; Lays Off 95% of Staff
May 8, 2025
·
1 min read
·
Dan Samorodnitsky
Job Trends
Job Market Woes: More Funding, Stability Needed for Turnaround
May 8, 2025
·
5 min read
·
Angela Gabriel
Layoff Tracker
Teva, Korro Shed Staff in Strategic Efforts
May 8, 2025
·
195 min read
·
BioSpace Editorial Staff
Earnings
Takeda Pledges $30B in U.S., Argues Against Trump’s ‘Most Favored Nations’ Proposal
May 8, 2025
·
2 min read
·
Tristan Manalac